PE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Pharmacy New Orleans (19 Museum)</title>
<style>
    body {
        font-family: Arial, sans-serif;
        margin: 40px;
        display: flex;
    }
    img {
        max-width: 30%;
        height: 100%;
        margin-right: 20px;
    }
    .content {
        max-width: 70%;
    }
</style>
</head>
<body>
<img src="../images/19thcenturymedicalsyringesPharmacyMuseumNewOrleans.jpg" alt="Pharmacy New Orleans (19 Museum)">
<div class="content">
<h1>Pharmacy New Orleans (19 Museum)</h1>

<h2>[a] Artist/ Group/Tribe</h2>
<p>This assemblage is best understood as the work of curators at the New Orleans Pharmacy Museum and of the many anonymous instrument makers who manufactured hypodermic needles, syringes, ampoules, and patent-medicine kits in the nineteenth and early twentieth centuries. The “authors” are thus both institutional and industrial: pharmacists who preserved the tools of their trade and early medical-device craftsmen who standardized forms like the Pravaz- and Wood-type syringe.</p>

<h2>[b] Historical and Socio-Cultural context (time-frame)</h2>
<p>The objects date largely from the mid-1800s to the early 1900s, a period spanning the rise of germ theory, antisepsis (after Lister in the 1860s), the professionalization of pharmacy, and new regulations such as the 1906 Pure Food and Drugs Act and the 1914 Harrison Narcotics Tax Act. In port cities such as New Orleans—cosmopolitan, multilingual, and disease-prone—pharmacists were frontline responders to yellow fever outbreaks, trauma, and chronic pain. The hypodermic syringe, introduced in the 1850s by Charles Pravaz and popularized by Alexander Wood, transformed dosage precision and enabled subcutaneous administration of morphine, cocaine, and later vaccines and antitoxins.</p>

<h2>[c] Symbolism and/ or iconography</h2>
<p>The metallic gleam of syringes, the opaque pewter barrel, and the regimented rows of ampoules signify clinical authority and the promise of modern technique. The compact sterilization tins and paper labels evoke an era when branding and therapeutic claims shaped public trust. The pointed needle functions iconographically as an instrument of penetration and cure—but also as a reminder of vulnerability, pain, and iatrogenic risk. The juxtaposition of elegant machining with worn patina suggests a narrative of repeated use and the intimate touch of caregiver and patient.</p>

<h2>[d] Stylistic Significance (elements of art/ principles of design)</h2>
<p>Formally, the display operates as an assemblage: repeated cylinders and shafts produce rhythm, while the contrast between glass transparency and darkened metals creates tonal variety. The tight, tool-box composition encourages close looking and indexical reading—labels act almost as captions in a didactic relief. Texture is paramount: knurled finger rings, smooth ampoules, and rough pewter emphasize tactility and mechanical ergonomics. The result bridges material culture and museological aesthetics, echoing cabinet-of-curiosity vitrines and, anachronistically, twentieth-century box constructions that mined ordinary objects for meaning.</p>

<h2>[e] Social / Cultural Inequities</h2>
<p>The history surrounding these instruments is entangled with inequities. In the nineteenth-century South, segregated facilities and unequal access meant that Black communities and the poor were more likely to encounter reused or inadequately sterilized equipment. Patent medicines often targeted women and laborers with misleading claims, fostering dependency on opiates. Regulatory reforms emerged partly to address these harms, yet enforcement lagged, and criminalization of narcotics later shifted burdens onto marginalized groups rather than expanding treatment.</p>

<h2>[f] Description of Disease & Etiology</h2>
<p>Two biomedical narratives are central here. First, injection-transmitted infections: before effective sterilization and single-use technology, shared needles could transmit pathogens such as hepatitis B and C or bacterial agents causing cellulitis and endocarditis. Etiologically, blood-to-blood contact and contaminated solutions were key vectors. Second, opioid use disorder (OUD) arose as morphine and later heroin were delivered subcutaneously for pain, neuralgia, or cough; pharmacologically, µ-opioid receptor activation produces analgesia, tolerance, and dependence, with withdrawal on cessation.</p>

<h2>[g] Pathology Signs/Signifiers of Illness</h2>
<p>Injection-related bacterial disease presents with erythema, warmth, fluctuance, and abscess formation; systemic spread can lead to fever, sepsis, and endocarditis (murmurs, septic emboli). Viral hepatitis C may be silent for years, progressing to chronic liver disease, cirrhosis, or hepatocellular carcinoma. OUD manifests as craving, escalating dose, withdrawal symptoms (myalgias, rhinorrhea, diarrhea), and social impairment. Historically, physicians also recognized “needle tracks” and localized necrosis as visible stigmata.</p>

<h2>[h] Treatment</h2>
<p>Historically, sterilization evolved from boiling and flaming to chemical antisepsis and eventually autoclaving; by the mid-twentieth century, disposable syringes reduced transmission. Bacterial skin and soft-tissue infections are managed with incision-and-drainage and appropriate antibiotics; endocarditis requires prolonged intravenous therapy. Chronic hepatitis C is now curable with direct-acting antivirals. For OUD, evidence-based treatments include methadone and buprenorphine, with naloxone for overdose reversal. Harm-reduction strategies—sterile syringe services, supervised consumption, and safe disposal—directly address risks implicit in the older multi-use devices on display.</p>

<h2>[i] Social Determinants of Illness</h2>
<p>Poverty, unstable housing, disaster dislocation, criminalization of drug use, and limited access to primary care shape exposure to unsafe injection and delayed treatment. In the era of these instruments, weak regulation and aggressive marketing compounded risks; in New Orleans specifically, epidemic cycles, labor patterns around the port, and segregated care produced differential vulnerability. Strengthening public health infrastructure, expanding coverage, and de-stigmatizing addiction are structural correctives to the inequities inscribed in this material history.</p>

<h2>[j] References and Citations</h2>
<ul>
<li>New Orleans Pharmacy Museum. https://www.pharmacymuseum.org</li>
<li>Science Museum Group: Hypodermic syringe (Pravaz type). https://collection.sciencemuseumgroup.org.uk/objects/co1211-hypodermic-syringe-pravaz-type</li>
<li>Encyclopaedia Britannica: Hypodermic syringe. https://www.britannica.com/technology/hypodermic-needle</li>
<li>Encyclopaedia Britannica: Joseph Lister and antisepsis. https://www.britannica.com/biography/Joseph-Lister</li>
<li>U.S. FDA: 1906 Pure Food and Drugs Act. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/1906-pure-food-and-drugs-act</li>
<li>Encyclopaedia Britannica: Harrison Narcotics Act. https://www.britannica.com/topic/Harrison-Narcotics-Act</li>
<li>CDC: Hepatitis C Information for Health Professionals. https://www.cdc.gov/hepatitis/hcv/index.htm</li>
<li>The Historic New Orleans Collection: Yellow Fever in New Orleans. https://www.hnoc.org/education/lesson-plans/yellow-fever</li>
<li>Encyclopaedia Britannica: Salvarsan. https://www.britannica.com/science/Salvarsan</li>
</ul>
</div>
</body>
</ht